RE: New Product Launch16 Aug 2024 18:24
30 Jan 24
"The Company has developed novel science, protected its commercial interests with a broad IP portfolio, has SweetBiotix®'s taste and texture and/or health potential confirmed independently by industry partners and in academic publications, and formed partnerships with a number of industry partners. These include DSM-Firmenich who have specialist expertise in taste and texture, manufacturing capability, and a global distribution network. Our US partner has shown SweetBiotix® can be manufactured to scale. Given the size of the challenge and considering the food industry is dominated by large global players with significant R&D capabilities this is a significant achievement for OptiBiotix. The focus now is on leveraging this position to fully exploit the market opportunity open to us and bring products containing SweetBiotix® to market. This is the focus of 2024."
27 Feb 24
The Company has included SweetBiotix® in a finished product for a large global partner with a view for an upcoming launch. The Company hopes to see SweetBiotix® in an increasing number of products launched throughout 2024.
The Company has received preliminary forecasts from DSM-Firmenich, one of its SweetBiotix® partners, of >100,000 metric tonne per annum. Whilst a preliminary forecast it demonstrates the scale of intent and the size of the opportunity.
Finally, we are pleased with progress on SweetBiotix®, its first introduction into a finished product, and the scale of the opportunity forecast by DSM Firmenich. We believe we have a number of substantive opportunities, any one of which would be transformational for the Company and shareholders alike, and collectively change the future of the business.
28 June 24
Second generation products (SweetBiotix and MicroBiome Modulators/Synbiotics)
As with any step change innovation this has been a long and difficult path with significant challenges,
particularly on scale up, and during the two years of COVID when development stopped. These
challenges have now been overcome and we have been pleased that the scale of the opportunity and
uniqueness of our patented approach has attracted the interest of major global partners both in the
manufacture (e.g DSM-Firmenich) and application of these products (e.g Coca Cola, Nestle, Arla etc).
These partners bring scale and global networks albeit time consuming and with stringent
confidentiality conditions. We have been pleased with the progress made by DSM-Firmenich and its
preliminary forecast for SweetBiotix® of >100,000 metric tonne per annum, demonstrating its intent
and potential scale of the opportunity. If this forecast materialises at an expected price of £30 per kg
this would represent substantial sales revenue. Experience tells us that partner forecasts tend to be
optimistic, increases in volume often take longer, and over time the sales price is likely to be eroded
to £18-£20 per kg, however this gives an indication of the potentia
Sign In
Follow the stocks
